NCT04485039View on ClinicalTrials.gov

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

December 15, 2022

Study Completion Date

April 23, 2023

Conditions
Smallpox
Interventions
DRUG

Tecovirimat

oral antiviral

DRUG

sevelamer carbonate oral tablet

phosphate binder

DRUG

sucroferric oxyhydroxide chewable tablet

phosphate binder

DRUG

calcium acetate oral tablet

phosphate binder

DRUG

Lanthanum Carbonate Chewable Tablet

phosphate binder

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors

Collaborators (1)

PPD Development, LP
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

collaborator

PPD Development, LP

INDUSTRY

lead

SIGA Technologies

INDUSTRY